|
1) 日本高血圧学会ガイドライン作成委員会, 編. 高血圧治療ガイドライン 2009. 東京: 日本高血圧学会; 2009
|
|
|
|
|
2) Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH2009). Hypertens Res. 2009; 32: 3-107
|
|
|
|
|
3) Katsuya T, Ishikawa K, Sugimoto K, et al. Salt sensitivity of Japanese from the viewpoint of gene Polymorphism. Hypertens Res. 2004; 26: 521-5
|
|
|
|
|
4) Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in nordiabetic people in China: a dietary intervention study. Lancet. 2009; 373: 829-35
|
|
|
|
|
5) Ogihara T, Nakao K, Fukui T, et al; Candesartan Antihypertensive Survival Evaluation in Japan Trial Group. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension. 2008; 51: 393-8
|
|
|
|
|
|
6) Mochizuki S, Dahlof B, Shimizu M, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease (JIKEI Heart study): a randomised open-label, blinded endpoint morbidity-mortality study. Lancet. 2007; 369: 1431-9
|
|
|
|
|
|
7) Ishii M, Goto Y, JATOS Study Group. Principal results of The Japanese Trial to assess Optimal Systolic blood pressure in elderly hypertensive patients. Hypertens Res. 2008; 31: 2115-27
|
|
|
|
|
|
8) Beckett NS, Peters R, Fletcher AF, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887-98
|
|
|
|
|
|
9) Ogihara T, Nakao K, Fukui T, et al. The Optimal target blood pressure for antihypertensive Treatment in the Japanese elderly patients with high-risk Hypertension a subanalysis of Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res. 2008; 31: 1595-601
|
|
|
|
|